SynthesisBMC cancer2021

Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis.

Sadayuki Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.